FDA Approved: GLUCOTROL XL — Supplemental Application (Roerig)

View source ↗

Summary

The FDA approved a supplemental application for Glucotrol XL (glipizide) submitted by Roerig under NDA 020329.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucotrol XL (glipizide)

Snippet

SUPPL AP for GLUCOTROL XL (GLIPIZIDE)